171 related articles for article (PubMed ID: 23736527)
1. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.
Gierth M; Fritsche HM; Buchner H; May M; Aziz A; Otto W; Bolenz C; Trojan L; Hermann E; Tiemann A; Müller SC; Ellinger J; Brookman-May S; Stief CG; Tilki D; Nuhn P; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Wieland WF; Riedmiller H; Denzinger S; Bastian PJ; Burger M
World J Urol; 2014 Apr; 32(2):365-71. PubMed ID: 23736527
[TBL] [Abstract][Full Text] [Related]
2. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
[TBL] [Abstract][Full Text] [Related]
3. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Shariat SF; Ehdaie B; Rink M; Cha EK; Svatek RS; Chromecki TF; Fajkovic H; Novara G; David SG; Daneshmand S; Fradet Y; Lotan Y; Sagalowsky AI; Clozel T; Bastian PJ; Kassouf W; Fritsche HM; Burger M; Izawa JI; Tilki D; Abdollah F; Chun FK; Sonpavde G; Karakiewicz PI; Scherr DS; Gonen M
Eur Urol; 2012 Feb; 61(2):237-42. PubMed ID: 22033174
[TBL] [Abstract][Full Text] [Related]
4. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
5. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
[TBL] [Abstract][Full Text] [Related]
6. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
[TBL] [Abstract][Full Text] [Related]
7. Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
Lee EK; Herr HW; Dickstein RJ; Kassouf W; Munsell MF; Grossman HB; Dinney CP; Kamat AM
BJU Int; 2012 Dec; 110(11 Pt B):E590-5. PubMed ID: 22758775
[TBL] [Abstract][Full Text] [Related]
8. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
9. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
[TBL] [Abstract][Full Text] [Related]
10. External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder.
Ku JH; Kim M; Byun SS; Jeong H; Kwak C; Kim HH; Lee SE
PLoS One; 2015; 10(10):e0120552. PubMed ID: 26426341
[TBL] [Abstract][Full Text] [Related]
11. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
[TBL] [Abstract][Full Text] [Related]
12. Lymph node dissection in bladder cancer. Impact on staging and prognosis.
Jensen JB
Dan Med J; 2012 Dec; 59(12):B4559. PubMed ID: 23290294
[TBL] [Abstract][Full Text] [Related]
13. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K
Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641
[TBL] [Abstract][Full Text] [Related]
14. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
[TBL] [Abstract][Full Text] [Related]
15. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.
Masson-Lecomte A; Xylinas E; Bouquot M; Sibony M; Allory Y; Comperat E; Zerbib M; de la Taille A; Rouprêt M
World J Urol; 2015 Aug; 33(8):1087-93. PubMed ID: 25179011
[TBL] [Abstract][Full Text] [Related]
17. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
[TBL] [Abstract][Full Text] [Related]
18. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
[TBL] [Abstract][Full Text] [Related]
19. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
20. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
